IL6 and renal cell carcinoma: The AMP-activated protein kinase (AMPK) is a negative key regulator of IL-6 and IL-8 production, and its activation appears to decrease RCC cell invasion in vitro and in ex vivo RCC cells from a human clear cell carcinoma [56].